Neil Lesser

[Neil Lesser @nlesser]

@SJosephBurns @engineers_feed 012

[Nick Turner @NewsyNick]

Today’s date (using U.S. style) is both a palindrome and an ambigram, which means it reads the same even if it’s flipped upside down.

[Neil Lesser @nlesser]

@TomGardnerFool Uh oh

[Neil Lesser @nlesser]

@NYinLA2121 What do you figure the temperature is?

[Neil Lesser @nlesser]

It’s war!!! #woodloch #youwilllose

[Neil Lesser @nlesser]

Sweet Spot Bakery - Rolling to Victory #woodloch #gingerbreadwars

[Neil Lesser @nlesser]

Sweet spot ready to beat all of you!!! #woodloch

[Neil Lesser @nlesser]

@DShaywitz @Deloitte @FT @nntaleb Apologies I should read bylines more carefully! Thanks again

[David Shaywitz @DShaywitz]

Recent @Deloitte report reminded us that pharma continues to struggle with R&D - costing more and more to get to a new drug. In this context, re-reading 2008 @FT essay w/@nntaleb - seems absolutely on target. https://t.co/pY1OoxiejW 1/2

[Colin Terry @colinterry]

Endpoints: FDA wants to help unproductive drugmakers via @TheEconomist quoting Deloitte Return on Investment analysis @nlesser

[Charles Oakley @CharlesOakley34]

#TBT to the 1994 All Star game

[Sonal Shah @Sonal_S_Shah]

Can emerging technology help biopharma improve the returns on R&D? https://t.co/Ht5L5w8oEu

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

There are 2,004 cancer immunotherapies crowding into the pipeline. Now what? [12/7/17] @JohnCendpts @endpts https://t.co/ldgM3zlUIt #ImmunoOnc HT @DrChoueiri

[Colin Terry @colinterry]

How are #pharma R&D returns faring in 2017? Find out here https://t.co/DigSfZsDDR

[Brett J Davis @BrettJDavis78]

How can pharmaceutical companies adapt to a digital environment? | Deloi... https://t.co/JCAtz0l6l6

[Sonal Shah @Sonal_S_Shah]

What type of deal generates the most value in #biopharma R&D? We explore #licensing, #MnA, and JV https://t.co/dRCevMSBjk @DeloitteInsight

[Neil Lesser @nlesser]

@davidnmartin @gardinier So did you!

[Neil Lesser @nlesser]

Great interview with @tomfriedman Tom Friedman interview with @Deloitte: Jobs, learning, and the future of work https://t.co/vqN1bOtw5d

[Neil Lesser @nlesser]

@nyinla2121 You've gotta ask me nicely